Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT03889275 |
| Title | A Study of MEDI5395 in Combination With Durvalumab in Subjects With Select Advanced Solid Tumors |
| Recruitment | Completed |
| Gender | both |
| Phase | Phase I |
| Variant Requirements | No |
| Sponsors | MedImmune LLC |
| Indications | |
| Therapies | |
| Age Groups: | senior | adult |
| Covered Countries | USA | GBR |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Research Site | Phoenix | Arizona | 85054 | United States | Details | |
| Research Site | La Jolla | California | 92093 | United States | Details | |
| Research Site | Rochester | Minnesota | 55905 | United States | Details | |
| Research Site | Buffalo | New York | 14263 | United States | Details | |
| Research Site | New York | New York | 10065 | United States | Details | |
| Research Site | Chapel Hill | North Carolina | 27599 | United States | Details | |
| Research Site | Pittsburgh | Pennsylvania | 15232 | United States | Details | |
| Research Site | Providence | Rhode Island | 02903 | United States | Details | |
| Research Site | Leeds | LS9 7TF | United Kingdom | Details | ||
| Research Site | London | SW3 6JJ | United Kingdom | Details |